These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 31595417)

  • 1. Newly Emerging Drugs of Abuse.
    Tamama K; Lynch MJ
    Handb Exp Pharmacol; 2020; 258():463-502. PubMed ID: 31595417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New Designer Drugs.
    Levine M; Lovecchio F
    Emerg Med Clin North Am; 2021 Aug; 39(3):677-687. PubMed ID: 34215409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adolescence and drug abuse: biomedical consequences.
    Cohen S
    NIDA Res Monogr; 1980; 38():104-12. PubMed ID: 6121291
    [No Abstract]   [Full Text] [Related]  

  • 4. Drugs of Abuse-Opioids, Sedatives, Hypnotics.
    Azevedo K; Johnson M; Wassermann M; Evans-Wall J
    Crit Care Clin; 2021 Jul; 37(3):501-516. PubMed ID: 34053703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of synthetic cannabinoids that were seized, consumed, or associated with deaths in Kuwait in 2018 using GC-MS and LC-MS-MS analysis.
    Al-Matrouk A; Alqallaf M; AlShemmeri A; BoJbarah H
    Forensic Sci Int; 2019 Oct; 303():109960. PubMed ID: 31550599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overdose Deaths Involving Opioids, Cocaine, and Psychostimulants - United States, 2015-2016.
    Seth P; Scholl L; Rudd RA; Bacon S
    MMWR Morb Mortal Wkly Rep; 2018 Mar; 67(12):349-358. PubMed ID: 29596405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fatal intoxication of a regular drug user following N-ethyl-hexedrone and ADB-FUBINACA consumption.
    Kovács K; Kereszty É; Berkecz R; Tiszlavicz L; Sija É; Körmöczi T; Jenei N; Révész-Schmehl H; Institóris L
    J Forensic Leg Med; 2019 Jul; 65():92-100. PubMed ID: 31128567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overview of Synthetic Cannabinoids ADB-FUBINACA and AMB-FUBINACA: Clinical, Analytical, and Forensic Implications.
    Lobato-Freitas C; Brito-da-Costa AM; Dinis-Oliveira RJ; Carmo H; Carvalho F; Silva JP; Dias-da-Silva D
    Pharmaceuticals (Basel); 2021 Feb; 14(3):. PubMed ID: 33669071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New and Emerging Illicit Psychoactive Substances.
    Graddy R; Buresh ME; Rastegar DA
    Med Clin North Am; 2018 Jul; 102(4):697-714. PubMed ID: 29933824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacology of Valinate and tert-Leucinate Synthetic Cannabinoids 5F-AMBICA, 5F-AMB, 5F-ADB, AMB-FUBINACA, MDMB-FUBINACA, MDMB-CHMICA, and Their Analogues.
    Banister SD; Longworth M; Kevin R; Sachdev S; Santiago M; Stuart J; Mack JB; Glass M; McGregor IS; Connor M; Kassiou M
    ACS Chem Neurosci; 2016 Sep; 7(9):1241-54. PubMed ID: 27421060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of concurrent substance use among adolescent nonmedical ADHD stimulant users.
    Chen LY; Crum RM; Strain EC; Martins SS; Mojtabai R
    Addict Behav; 2015 Oct; 49():1-6. PubMed ID: 26026384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the primary care physician in problems of substance abuse.
    Weaver MF; Jarvis MA; Schnoll SH
    Arch Intern Med; 1999 May; 159(9):913-24. PubMed ID: 10326934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical toxicology of newer recreational drugs.
    Hill SL; Thomas SH
    Clin Toxicol (Phila); 2011 Oct; 49(8):705-19. PubMed ID: 21970769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Illicit Drugs and their Impact on Cardiovascular Pathology.
    Bădilă E; Hostiuc M; Weiss E; Bartoş D
    Rom J Intern Med; 2015; 53(3):218-25. PubMed ID: 26710497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Next generation of novel psychoactive substances on the horizon - A complex problem to face.
    Zawilska JB; Andrzejczak D
    Drug Alcohol Depend; 2015 Dec; 157():1-17. PubMed ID: 26482089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions between opioids and stimulants: Behavioral pharmacology of abuse-related effects.
    Maguire DR; Minervini V
    Adv Pharmacol; 2022; 93():1-33. PubMed ID: 35341563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Descriptive, observational study of pharmaceutical and non-pharmaceutical arrests, use, and overdoses in Maine.
    Simpson KJ; Moran MT; Foster ML; Shah DT; Chung DY; Nichols SD; McCall KL; Piper BJ
    BMJ Open; 2019 Apr; 9(4):e027117. PubMed ID: 31036710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Schedules of Controlled Substances: Temporary Placement of Six Synthetic Cannabinoids (5F-ADB, 5F-AMB, 5F-APINACA, ADB-FUBINACA, MDMB- CHMICA and MDMB-FUBINACA) Into Schedule I. Notice of Intent.
    Drug Enforcement Administration, Department of Justice
    Fed Regist; 2016 Dec; 81(245):93595-9. PubMed ID: 28068047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case of 5F-ADB / FUB-AMB abuse: Drug-induced or drug-related death?
    Ivanov ID; Stoykova S; Ivanova E; Vlahova A; Burdzhiev N; Pantcheva I; Atanasov VN
    Forensic Sci Int; 2019 Apr; 297():372-377. PubMed ID: 30850157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phantom menace: novel psychoactive substances and the UK Armed Forces.
    Hunter AH; Ayres T; Moreland N; Cox A
    J R Army Med Corps; 2018 Nov; 164(6):450-457. PubMed ID: 29934414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.